STOCKSCOPE

ASX Sells Off as Paladin Slumps 17%: Rising Bond Yields and NVIDIA Shock Rattle Global Markets

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:5h ago
ASX Sells Off as Paladin Slumps 17%: Rising Bond Yields and NVIDIA Shock Rattle Global Markets

Australian equities: what moved the ASX 200?

Australian shares finished Friday, 13 November, under pressure, with the S&P/ASX 200 falling 65.4 points, or 0.71%, to close at 9,082.2. The index traded between 9,056.6 and 9,108.6, leaving it approximately 0.7% higher for the week. Market breadth was firmly negative, with 686 stocks declining, 330 advancing and 307 unchanged.

Eight of the 11 major sectors finished lower, with materials, mining and technology among the weakest. The selling reflected a combination of weaker global sentiment, pressure on commodity prices and concerns about rising bond yields.

Paladin Energy (ASX: PDN) was one of the session's biggest casualties, plunging 17.13% to A$7.21. The decline followed completion of its A$525 million equity raising, comprising an approximately A$499 million institutional placement and a A$26 million Canadian placement, priced at A$7.80 per share for the Australian component. The funding will support development of its Patterson Lake South uranium project in Canada, resource growth at its existing operations and exploration. While the additional capital strengthens its funding position, the discounted placement creates dilution for existing shareholders.

Lendlease Group (ASX: LLC) also struggled, falling 6.83% to A$2.32. The property group announced plans to redeem approximately A$1.22 billion of outstanding bonds using an existing A$1.25 billion standby facility. Although liquidity is expected to remain above A$2.5 billion, approximately A$57 million in make-whole and hedge termination costs highlights the expense of restructuring its funding arrangements.

GrainCorp (ASX: GNC) provided some support, although its closing price was A$7.21, rather than the higher intraday price reported during the session.

The Australian dollar, bonds and the RBA

The Australian dollar finished around US$0.6808, having weakened considerably earlier in the week. Meanwhile, Australia's 10-year government bond yield climbed to approximately 5.13%, up around 2.4 basis points from Thursday.

The RBA's November decision lifted the official cash rate by 25 basis points to 4.85%, effective 4 November. Persistent inflation pressures remain a concern, particularly as higher energy costs threaten to complicate the inflation outlook.

The combination of restrictive monetary policy and rising longer-term yields creates a challenging environment for property, technology and other companies whose valuations are particularly sensitive to financing costs.

Global markets: China, Asia and Europe

Asian markets traded unevenly on Friday. Early trading saw Japan's Nikkei 225 rise 1.64% and South Korea's Kospi advance 1.68%, while Hong Kong's Hang Seng declined 0.59%. China's Shanghai Composite was modestly higher in the same early-session snapshot.

The divergence highlights the competing forces influencing regional markets. Technology-related optimism provided some support, but concerns about Chinese industrial demand remain important for Australia's resources sector.

European markets had not yet commenced Friday's trading session at the Sydney reporting cutoff.

Wall Street: US stocks and the Federal Reserve

Wall Street finished Thursday lower following a volatile session. The S&P 500 declined 0.35% to 7,592.40, the Nasdaq Composite fell 0.39% to 25,366.09, and the Dow Jones Industrial Average lost 0.36% to 52,297.09. The Russell 2000 underperformed, dropping 1.66% to 2,799.06.

The standout corporate development was NVIDIA's (NASDAQ: NVDA) announcement that chief executive Jensen Huang had resigned, with chief financial officer Colette Kress appointed interim chief executive. NVIDIA shares fell 4.34%, although other semiconductor companies performed better, with Broadcom gaining 5.54% and Advanced Micro Devices rising 5.86%.

US Treasury yields added to market pressure. The two-year yield reached approximately 4.86%, while the 10-year yield climbed to 5.10%. These increases reflect growing concerns about inflation and the potential for monetary policy to remain restrictive.

Friday's US session had not yet opened at our reporting cutoff, making Thursday's closing prices the latest completed figures.

Commodities: gold, oil and industrial metals

Commodity markets delivered mixed signals. December gold futures recovered to approximately US$3,919 an ounce, gaining around 0.88% in the latest available session snapshot. Gold's resilience reflects continuing demand for portfolio protection amid geopolitical uncertainty and changing interest rate expectations.

Oil remained elevated, with December WTI futures around US$88.27 a barrel and January Brent futures near US$95.62. Geopolitical tensions involving Iran and concerns about supply disruptions continued to influence energy markets.

Copper futures were around US$6.19 a pound, while iron ore traded near US$92 a tonne. Weaker industrial metals remain a concern for Australian miners, particularly if Chinese demand fails to improve.

What to watch next

Next week, attention will turn to US inflation and economic developments, movements in Treasury yields, Chinese industrial demand and the sustainability of the Australian dollar's recovery.

Paladin's placement settlement is scheduled for 18 November, with new shares expected to be allotted on 19 November. Its proposed shareholder purchase plan is scheduled to open on 23 November, providing another important development for the uranium sector.

Our assessment is that markets are increasingly sensitive to the combination of expensive money, geopolitical uncertainty and uneven commodity demand. The key question is whether corporate earnings can continue supporting equity valuations while bond yields rise. Until that tension becomes clearer, we believe selectivity, balance sheet strength and genuine earnings growth will remain the defining themes of the market.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

Carma (ASX: CMA) Doubles Gross Profit as Vehicle Sales Surge, Setting the Stage for Its Next Growth Phase
Consumer
Consumer

Carma (ASX: CMA) Doubles Gross Profit as Vehicle Sales Surge, Setting the Stage for Its Next Growth Phase

Carma Limited ASX: CMA is building momentum in Australia's online used-car market, with annual gross profit more than doubling and vehicle sales surging 86%. Its 13 November 2026 annual gene...

Alison ElzayedAlison Elzayed•
Imricor Medical Systems (ASX: IMR) Sees US Revenue Surge 437% as Hospital Expansion Opens New Growth Opportunities
Biotech & Health
Biotech & Health

Imricor Medical Systems (ASX: IMR) Sees US Revenue Surge 437% as Hospital Expansion Opens New Growth Opportunities

Imricor Medical Systems ASX: IMR is gaining commercial momentum in the United States, with September-quarter revenue climbing 437% as its innovative cardiac technology begins generating s...

Danny AadDanny Aad•
Neurizon Therapeutics (ASX: NUZ) Advances ALS Treatment Towards Pivotal 2027 Results as $12 Million Funding Facility Strengthens Outlook
Biotech & Health
Biotech & Health

Neurizon Therapeutics (ASX: NUZ) Advances ALS Treatment Towards Pivotal 2027 Results as $12 Million Funding Facility Strengthens Outlook

Neurizon Therapeutics ASX: NUZ is building momentum towards a potentially transformative clinical milestone, with two developments on 13 November 2026 strengthening its position ahead of piv...

Danny AadDanny Aad•
Artrya (ASX: AYA) Secures Fifth US Hospital Deal as Commercial Momentum Builds in $580 Million Growth Story
Biotech & Health
Biotech & Health

Artrya (ASX: AYA) Secures Fifth US Hospital Deal as Commercial Momentum Builds in $580 Million Growth Story

Artrya Limited ASX: AYA is gaining momentum in the US healthcare market, securing a five-year agreement with Arizona-based HonorHealth worth at least US$500,000. The 13 November announcemen...

Danny AadDanny Aad•
Omega Oil & Gas (ASX: OMA) Hits Gas at Queensland’s Deepest Well as Taroom Trough Opportunity Grows
Energy
Energy

Omega Oil & Gas (ASX: OMA) Hits Gas at Queensland’s Deepest Well as Taroom Trough Opportunity Grows

Gas reaching the surface and the highest gas shows recorded to date have added fresh momentum to Omega Oil & Gas Limited ASX: OMA, strengthening the emerging resource story in Queensland’s T...

Alison ElzayedAlison Elzayed•
Big River Industries (ASX: BRI) Secures $156 Million Takeover Deal at 45.9% Premium as Earnings Recovery Gains Momentum
Industrials
Industrials

Big River Industries (ASX: BRI) Secures $156 Million Takeover Deal at 45.9% Premium as Earnings Recovery Gains Momentum

Big River Industries ASX: BRI has secured a $1.62-per-share cash takeover proposal, valuing the building products manufacturer and distributor at approximately $156 million. The agreement r...

Alison ElzayedAlison Elzayed•
Loading more stories...